Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy
Journal of Hepatocellular Carcinoma · 2026-11 · Volume 13 · 1-14
DOI: 10.2147/jhc.s655212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-11. Verfasst von Dan Huang und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Huang, D., Chen, X., & Zhuang, P. (2026). Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s655212
Vancouver
Huang D, Chen X, Zhuang P. Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s655212
BibTeX
@article{Huang2026,
author = {Huang, Dan and Chen, Xiaoke and Zhuang, Peng},
title = {Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--14},
doi = {10.2147/jhc.s655212}
}
EUVIMED